The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer
- PMID: 23635341
- DOI: 10.1111/jsm.12156
The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer
Abstract
Introduction: Almost half of breast cancer survivors experience chronic sexual problems. Despite the negative effects of dyspareunia on physical and overall quality of life, sexual dysfunction remains underreported and undertreated in clinical practice. This is likely due to the paucity of evidence-based interventions to improve sexual functioning.
Aim: The study aims to prospectively evaluate the acceptability, feasibility, and efficacy of a novel intervention (Olive Oil, Vaginal Exercise, and MoisturizeR [OVERcome]) to improve sexual problems following breast cancer treatment.
Main outcome measures: Dyspareunia, sexual functioning, quality of life, distress, and pelvic floor muscles (PFMs) functioning were evaluated.
Methods: Twenty-five women with dyspareunia were instructed to perform pelvic floor muscle (PFM) relaxation exercises twice/day to prevent/manage PFM overactivity, apply a polycarbophil-based vaginal moisturizer three times/week to alleviate vaginal dryness, use olive oil as a lubricant during intercourse, and complete a weekly compliance diary. PFM relaxation training was administered by a physiotherapist at weeks 0 and 4, with follow-up at weeks 12 and 26. At each visit, women completed validated self-report questionnaires and the physiotherapist recorded objective measures of PFM functioning.
Results: OVERcome resulted in significant improvements in dyspareunia, sexual function, and quality of life over time (all P<0.001). PFM relaxation training was reported to be effective (P≤0.001). Maximum benefits were observed at week 12. Most women rated PFM relaxation exercises (92%), vaginal moisturizer (88%), and olive oil (73%) as helpful, indicating that the intervention was acceptable. Unexpectedly, six cases (11%) of vaginal stenosis were noted during initial screening.
Conclusions: This novel intervention is acceptable to patients with demonstrated efficacy in improving dyspareunia and sexual function following breast cancer. Delivery of the OVERcome intervention appears feasible in a clinical setting, providing a potential treatment for this important clinical issue. The unexpected number of observed cases of stenosis further highlights the underreporting of sexual problems in this population, deserving further exploration.
Keywords: Breast Cancer; Dyspareunia; Pelvic Floor Muscle Relaxation Exercises; Sexual Functioning; Vaginal Dryness; Vaginal Lubricant/Moisturizer.
© 2013 International Society for Sexual Medicine.
Similar articles
-
Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study.Menopause. 2016 Jul;23(7):816-20. doi: 10.1097/GME.0000000000000620. Menopause. 2016. PMID: 27219835
-
Feasibility, acceptability and effects of multimodal pelvic floor physical therapy for gynecological cancer survivors suffering from painful sexual intercourse: A multicenter prospective interventional study.Gynecol Oncol. 2020 Dec;159(3):778-784. doi: 10.1016/j.ygyno.2020.09.001. Epub 2020 Oct 1. Gynecol Oncol. 2020. PMID: 33010968 Clinical Trial.
-
Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:92-95. doi: 10.1016/j.ejogrb.2018.12.040. Epub 2019 Jan 11. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 30677618
-
Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.Am J Obstet Gynecol. 2020 Feb;222(2):103-113. doi: 10.1016/j.ajog.2019.08.043. Epub 2019 Aug 29. Am J Obstet Gynecol. 2020. PMID: 31473229 Review.
-
What Does Electromyography Tell Us About Dyspareunia?Sex Med Rev. 2017 Jul;5(3):282-294. doi: 10.1016/j.sxmr.2017.02.001. Epub 2017 Mar 18. Sex Med Rev. 2017. PMID: 28330675 Review.
Cited by
-
Efficacy and Safety of Treatments to Improve Dyspareunia in Breast Cancer Survivors: A Systematic Review.Breast Care (Basel). 2020 Dec;15(6):599-607. doi: 10.1159/000506148. Epub 2020 Feb 24. Breast Care (Basel). 2020. PMID: 33447234 Free PMC article.
-
Breast cancer and sexual function.Transl Androl Urol. 2015 Apr;4(2):160-8. doi: 10.3978/j.issn.2223-4683.2014.12.04. Transl Androl Urol. 2015. PMID: 26816822 Free PMC article. Review.
-
The Role of Physical Exercise in Sexual Health and Body Image in Women Living with and Surviving Breast Cancer: A Scoping Review.Healthcare (Basel). 2025 Mar 26;13(7):741. doi: 10.3390/healthcare13070741. Healthcare (Basel). 2025. PMID: 40218039 Free PMC article. Review.
-
The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer.Support Care Cancer. 2019 Apr;27(4):1325-1334. doi: 10.1007/s00520-019-04684-6. Epub 2019 Feb 7. Support Care Cancer. 2019. PMID: 30729333 Clinical Trial.
-
A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.J Cancer Surviv. 2017 Aug;11(4):477-485. doi: 10.1007/s11764-017-0606-3. Epub 2017 Feb 22. J Cancer Surviv. 2017. PMID: 28229275 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical